ArticlemAbs

Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A.

Songmao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.